CD8A and neoplasm: Tumor heterogeneity in the TME is characterized by distinct immune phenotypes, including immune-inflamed tumors with abundant T cell infiltration and immune-desert tumors with a paucity of CD8+ T cells, leading to differential therapeutic outcomes.